0001666690-18-000005.txt : 20180212 0001666690-18-000005.hdr.sgml : 20180212 20180212162903 ACCESSION NUMBER: 0001666690-18-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180212 DATE AS OF CHANGE: 20180212 EFFECTIVENESS DATE: 20180212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-305405 FILM NUMBER: 18596804 BUSINESS ADDRESS: STREET 1: 2655 FIRST STREET STREET 2: SUITE 250 CITY: SIMI VALLEY STATE: CA ZIP: 93065 BUSINESS PHONE: 805-955-4190 MAIL ADDRESS: STREET 1: 2655 FIRST STREET STREET 2: SUITE 250 CITY: SIMI VALLEY STATE: CA ZIP: 93065 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 D 1 primary_doc.xml X0708 D LIVE 0001551986 INNOVATE BIOPHARMACEUTICALS, INC. 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 919-275-1933 DELAWARE WRASP 35, Inc. Monster Digital, Inc. Tandon Digital, Inc. Corporation true Jay Madan c/o Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Sandeep Laumas c/o Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Christopher Prior c/o Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Roy Proujansky c/o Innovate Biopharmaceuticals, Inc 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Lorin Johnson c/o Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Anthony Maida c/o Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Anna Kazanchyan c/o Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Biotechnology Decline to Disclose 06b false 2018-01-29 false true true true true 0 92751768 92751768 0 Total Offering Amount represents the aggregate offering amount of common shares and warrants to purchase common stock issued pursuant to a merger agreement. false 194 0 0 0 false INNOVATE BIOPHARMACEUTICALS, INC. /s/ Jay Madan Jay Madan President 2018-02-12